High Tide (HITI) | Financial Analysis & Statements
High Tide Inc. Micro-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jan 2026Income Metrics
Revenue
178.3M
Gross Profit
44.4M
24.90%
Operating Income
4.1M
2.32%
Net Income
-352.0K
-0.20%
EPS (Diluted)
$0.01
Balance Sheet Metrics
Total Assets
349.1M
Total Liabilities
246.3M
Shareholders Equity
102.8M
Debt to Equity
2.40
Cash Flow Metrics
Operating Cash Flow
-43.7M
Free Cash Flow
1.2M
Revenue & Profitability Trend
Quarter Income Flow
Jan 31, 2026
Annual Income Flow
2025
High Tide Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 594.0M | 386.4M | 487.7M | 356.9M | 181.1M |
| Cost of Goods Sold | 440.5M | 281.0M | 356.4M | 255.9M | 117.1M |
| Gross Profit | 153.5M | 105.4M | 131.3M | 101.0M | 64.0M |
| Gross Margin % | 25.8% | 27.3% | 26.9% | 28.3% | 35.3% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 113.8M | 75.3M | 101.2M | 90.9M | 54.3M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 113.8M | 75.3M | 101.2M | 90.9M | 54.3M |
| Operating Income | 15.4M | 11.3M | -2.7M | -20.1M | -13.8M |
| Operating Margin % | 2.6% | 2.9% | -0.5% | -5.6% | -7.6% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | 0 |
| Interest Expense | 13.4M | 9.5M | 11.6M | 9.9M | 10.2M |
| Other Non-Operating Income | -53.5M | -5.1M | -34.3M | -43.7M | -11.7M |
| Pre-tax Income | -51.4M | -3.3M | -48.6M | -73.8M | -35.8M |
| Income Tax | -25.0K | -438.7K | -7.6M | -2.9M | -730.0K |
| Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Income | -51.4M | -2.8M | -41.0M | -70.8M | -35.0M |
| Net Margin % | -8.7% | -0.7% | -8.4% | -19.9% | -19.3% |
| Key Metrics | |||||
| EBITDA | 39.7M | 29.5M | 30.6M | 10.1M | 9.7M |
| EPS (Basic) | $-0.62 | $-0.05 | $-0.53 | $-1.14 | $-0.84 |
| EPS (Diluted) | $-0.62 | $-0.05 | $-0.53 | $-1.14 | $-0.84 |
| Basic Shares Outstanding | 82178620 | 59762195 | 105443361 | 89053247 | 60193594 |
| Diluted Shares Outstanding | 82178620 | 59762195 | 105443361 | 89053247 | 60193594 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
High Tide Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 47.9M | 35.0M | 30.1M | 25.1M | 14.0M |
| Short-term Investments | 64.0K | 526.7K | 141.0K | 195.0K | 860.0K |
| Accounts Receivable | 5.6M | 2.4M | 7.6M | 7.9M | 6.5M |
| Inventory | 67.4M | 21.7M | 26.0M | 23.4M | 17.0M |
| Other Current Assets | - | - | - | - | - |
| Total Current Assets | 136.9M | 63.5M | 68.6M | 64.1M | 46.3M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 3.9M | 2.9M | 3.9M | 2.9M | 0 |
| Goodwill | 219.7M | 122.9M | 179.7M | 228.9M | 222.2M |
| Intangible Assets | 39.4M | 14.4M | 27.3M | 62.1M | 62.3M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 1.3M | - | - | - | 0 |
| Total Non-Current Assets | 212.2M | 118.7M | 164.8M | 210.7M | 199.9M |
| Total Assets | 349.1M | 182.1M | 233.4M | 274.7M | 246.2M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 27.8M | 6.0M | 8.4M | 7.7M | 8.7M |
| Short-term Debt | 27.5M | 26.4M | 32.2M | 26.7M | 12.3M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 10.0M | - | 3.7M | 6.3M | 10.0M |
| Total Current Liabilities | 99.9M | 45.5M | 58.1M | 59.9M | 40.8M |
| Non-Current Liabilities | |||||
| Long-term Debt | 121.4M | 28.8M | 40.3M | 43.2M | 43.2M |
| Deferred Tax Liabilities | 7.1M | 210.1K | 1.3M | 9.6M | 8.6M |
| Other Non-Current Liabilities | - | - | - | - | - |
| Total Non-Current Liabilities | 146.4M | 29.0M | 41.6M | 52.8M | 53.4M |
| Total Liabilities | 246.3M | 74.5M | 99.7M | 112.7M | 94.2M |
| Equity | |||||
| Common Stock | 329.6M | 222.4M | 288.0M | 279.5M | 208.9M |
| Retained Earnings | -260.1M | -154.9M | -205.9M | -168.1M | -87.8M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 102.8M | 107.6M | 133.7M | 162.0M | 152.0M |
| Key Metrics | |||||
| Total Debt | 148.9M | 55.2M | 72.5M | 69.9M | 55.4M |
| Working Capital | 37.0M | 18.0M | 10.5M | 4.1M | 5.5M |
Balance Sheet Composition
High Tide Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -51.4M | -2.8M | -41.0M | -70.8M | -35.0M |
| Depreciation & Amortization | 24.3M | 18.8M | 32.8M | 30.2M | 23.6M |
| Stock-Based Compensation | 3.9M | 2.2M | 5.0M | 8.1M | 4.9M |
| Working Capital Changes | -1.2M | 1.0M | -1.5M | -6.0M | -8.8M |
| Operating Cash Flow | -24.7M | 21.9M | -7.6M | -36.6M | -9.8M |
| Investing Activities | |||||
| Capital Expenditures | -10.4M | -6.7M | -5.8M | -7.8M | -10.6M |
| Acquisitions | -12.3M | -443.8K | 270.0K | 463.0K | -19.7M |
| Investment Purchases | - | -488.2K | - | 0 | -507.0K |
| Investment Sales | 648.0K | - | 95.0K | 0 | 0 |
| Investing Cash Flow | -22.1M | -7.6M | -5.4M | -7.3M | -28.3M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | - | - | 0 | 0 |
| Debt Issuance | 4.4M | 6.5M | 0 | 25.8M | 4.0M |
| Debt Repayment | -27.9M | -14.5M | -14.0M | -29.6M | -15.1M |
| Financing Cash Flow | -4.2M | -11.0M | -12.3M | 10.8M | 22.9M |
| Free Cash Flow | 13.2M | 19.1M | 14.6M | -4.6M | -13.5M |
| Net Change in Cash | -50.9M | 3.3M | -25.4M | -33.1M | -15.3M |
Cash Flow Trend
High Tide Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
-3.89
Forward P/E
16.82
Price to Book
3.26
Price to Sales
0.33
PEG Ratio
0.03
Profitability Ratios
Profit Margin
-7.42%
Operating Margin
2.32%
Return on Equity
-39.72%
Return on Assets
3.87%
Financial Health
Current Ratio
1.43
Debt to Equity
110.31
Beta
1.02
Per Share Data
EPS (TTM)
$-0.40
Book Value per Share
$0.73
Revenue per Share
$7.51
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| HITI | 211.0M | -3.89 | 3.26 | -39.72% | -7.42% | 110.31 |
| Walgreens Boots | 10.4B | 27.10 | 1.44 | -69.58% | -4.07% | 409.88 |
| PetMed Express | 47.7M | 257.00 | 1.50 | -100.61% | -34.70% | 1.99 |
| Wellgistics Health | 17.3M | - | - | 813.59% | -27.54% | -1.97 |
| Scienture Holdings | 17.0M | 0.56 | 0.24 | -55.65% | 76.80% | 0.03 |
| Hong Kong Pharma | 14.6M | 6.26 | 1.47 | -13.38% | -4.29% | 44.19 |
Financial data is updated regularly. All figures are in the company's reporting currency.





